Beta thalassaemia mutations in Turkish Cypriots.

Area of Science:

• Genetics
• Molecular Biology
• Hematology

Background:

• Thalassaemia major and intermedia are significant inherited blood disorders.
• Identifying specific genetic mutations is crucial for effective population screening and management.
• The Turkish Cypriot population has a notable prevalence of beta thalassaemia.

Purpose of the Study:

• To characterize the molecular defects responsible for beta thalassaemia in Turkish Cypriot patients.
• To identify the most common beta thalassaemia mutations in this population.
• To provide data for the development of a large-scale prevention program.

Main Methods:

• Oligonucleotide hybridisation was employed to detect specific DNA sequences.
• Restriction endonuclease analysis was used to identify variations in DNA.
• Molecular characterization was performed on 94 patients with thalassaemia major and 4 with thalassaemia intermedia.

Main Results:

• Four mutations were found to be prevalent: beta+ IVS-1 nt 110 (69.9%), beta zero IVS-1 nt (11.7%), beta+ IVS-1 nt 6 (8.7%), and beta+ IVS-2 nt 745 (5.6%).
• These four mutations accounted for a significant majority of the beta thalassaemia chromosomes analyzed.
• The study identified the specific genetic underpinnings of beta thalassaemia in the studied cohort.

Conclusions:

• The identified prevalent mutations provide a molecular basis for beta thalassaemia in the Turkish population.
• This genetic information is vital for establishing effective screening and prevention strategies.
• DNA-based fetal diagnosis can be instrumental in organizing a large-scale prevention program for beta thalassaemia.